Zylox-Tonbridge
Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Cangqian Street, Yuhang District, Hangzhou, Zhejiang, 311121, China
Overview
Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China. Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Biotechnology
- Health Care
- Medical Device
Investment portfolio
- Zylox
Led · Equity · Mar 2024
Zylox-Tonbridge develops and manufactures neuro‑ and peripheral‑vascular interventional medical devices with in‑house R&D, proprietary technological platforms, and commercial capabilities. The company emphasizes cost‑efficient manufacturing to produce high‑quality, affordable devices and services. It aims to expand its peripheral product portfolio for peripheral artery disease (PAD) and to offer a more comprehensive vessel preparation solution. Zylox-Tonbridge has entered a strategic partnership with Avinger to introduce OCT‑guided vascular treatment technology into Greater China and to support Avinger's global sales via technology transfer. The collaboration also creates reciprocal distribution opportunities for Zylox‑Tonbridge products in the U.S. and Germany. The company states this deal is a step toward global expansion and accelerating growth in China’s peripheral vascular intervention market.
Team
Zhong "Jonathon" Zhao
Chief Executive Officer
LinkedIn